2m 2m 2m 2m 2m 2m 2m
AURA BIOSCIS (AURA)
NASDAQ
$7.61-$0.04 (-0.52%)
Price as of Nov 11, 2026 6:49 PM EST- $793.3MMarket Cap
- 35.16%1-Year Change
- BiotechnologyIndustry
AURA BIOSCIS (AURA)
$7.61-$0.04 (-0.52%)
AURA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $7.65 | ||
Change | -$0.010 (-0.13%) | ||
Open | $7.65 | ||
High | $7.95 | ||
Low | $7.42 | ||
Previous Close | $7.66 | ||
Volume | 875,183 | ||
30-Day Average Volume | 838,915 | ||
1-Week Change | 22.60% | ||
1-Month Change | 16.97% | ||
1-Year Change | 35.16% | ||
3-Year Change | -0.52% | ||
5-Year Change | -52.95% | ||
Fundamentals | |||
Shares Outstanding | 103.7M | ||
Total Assets | $321.6M | ||
Market Cap | $793.3M | ||
Enterprise Value | $751.7M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$32.1M | ||
Free Cash Flow | -$26.5M | ||
EBIT | -$32.0M | ||
EBITDA | -$31.8M | ||
Net Working Capital | $281.8M | ||
EPS | -$0.29 | ||
Enterprise Value/EBITDA | -24 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -26 | ||
PEG | -1 | ||
Price/Free Cash Flow | -30 | ||
Price/Operating Cash Flow | -30 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue